The need to verify circumstances related to a reported adverse post-vaccination reaction associated with potential administration of the medicinal product. Analysis of the collected documentation did not confirm a threat to public health. Potential effects: possible more severe post-vaccination reactions and a risk to patients’ health.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
The product may be used in accordance with the doctor’s recommendations and the Summary of Product Characteristics; if any worrying symptoms occur after vaccination, patients should contact a doctor a...
The Chief Pharmaceutical Inspector revoked decision No. 17/WS/2024 suspending distribution of batch UFA 22507 of the Euvax B vaccine and discontinued the first-instance proceedings in their entirety.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related